The offer, which is not conditional on any minimum level of acceptances will be open between 29th April 2002 and 28th May 2002. The offer price will be 375 Rps per share payable in cash. The offer price represents a 31% premium on the average price for the week ending 1st March 2002 and a 44% premium on the average price for the previous six months.
AstraZeneca Pharma India Ltd manufactures and markets a range of cardiovascular, inhalation, cough, anaesthetics and maternal healthcare products. The business has 1500 employees.
|
Ross Horsburgh +65 633 97022
Chris Major +44 (0)20 7304 5028
|